• Cannabinoids and Sickle Cell

  • Sep 11 2022
  • Length: 1 hr and 19 mins
  • Podcast
Cannabinoids and Sickle Cell cover art

Cannabinoids and Sickle Cell

Listen for free

View show details

  • Summary

  • During this First Friday conversation, Marijuana Matters talks about Cannabinoids and Sickle Cell Disease (SCD). SCD affects approximately 8% of African Americans, and is characterized by chronic pain and episodic acute pain caused by Vaso occlusive crises, often requiring high doses of opioids for prolonged periods. Evidence is growing that cannabis may help people manage pain from SCD. However, only nine states include sickle cell as an approved health condition for medical marijuana. This conversation was moderated by Marijuana Matters Executive Director Courtney Davis, SCD advocate Demitrious Wyant aka AR the Prophet, and Cannabis Nurse Rebecca Abraham, CEO, and Founder of Acute on Chronic, LLC.

    Stay tuned by following Marijuana Matters on these platforms:

    • @marijuanamattersdc (IG)
    • Marijuana Matters (LinkedIn)
    • @socialequitymatters (Facebook)
    Show more Show less
Management & Leadership Economics
Show more Show less

What listeners say about Cannabinoids and Sickle Cell

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.ca reviews

Amazon Reviews
No reviews are available